Practice Pearl 2: Review of Studies for Prevention of VTE

Paul Ament, PharmD, reviews the data from studies looking into the prevention of VTEs and Riley Bowers, PharmD, shares the real-world data to the studies.

EP: 1.Overview of Venous Thromboembolism

EP: 2.Evolution of Therapies to Prevention of Venous Thromboembolism

EP: 3.Risks and Risk Factors Associated with VTE

EP: 4.Identifying the Rate of VTE Postdischarge

EP: 5.Practice Pearl 1: Tools Used for VTE Risk Assessment

EP: 6.Practice Pearl 1: ISTH Recommendations & Pharmacists’ Role in Identifying Risk of VTE

EP: 7.Practice Pearl 2: Review Guidelines for the Prevention of VTE

EP: 8.Practice Pearl 2: Review Guidelines for the Treatment of VTE

EP: 9.Practice Pearl 2: Review of the Direct Oral Anticoagulants for VTE

EP: 10.Practice Pearl 2: Dose Adjustments of DOACs for Obese or Renal Insufficiency

Now Viewing

EP: 11.Practice Pearl 2: Review of Studies for Prevention of VTE

EP: 12.Practice Pearl 2: Risks and Benefits of the Role of DOACs for Prevention of VTE

EP: 13.Practice Pearl 3: Dosage Forms of Treatment for VTE Prevention

EP: 14.Practice Pearl 3: Challenges in Managing VTE

Related Videos